JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

Search

Privia Health Group Inc

Geschlossen

BrancheGesundheitswesen

19.48 -0.97

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

19.4

Max

19.84

Schlüsselkennzahlen

By Trading Economics

Einkommen

679K

6M

Verkäufe

19M

480M

KGV

Branchendurchschnitt

164.167

38.156

Gewinnspanne

1.259

Angestellte

1,140

EBITDA

39K

7.1M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+50.25% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-427M

2.4B

Vorheriger Eröffnungskurs

20.45

Vorheriger Schlusskurs

19.48

Nachrichtenstimmung

By Acuity

50%

50%

157 / 375 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Privia Health Group Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Juli 2025, 23:57 UTC

Akquisitionen, Fusionen, Übernahmen

EQT: To Spend Y407.82B for Tender Offer

29. Juli 2025, 23:56 UTC

Akquisitionen, Fusionen, Übernahmen

EQT: Tender Offer Price Is Y5,700 a Share

29. Juli 2025, 23:54 UTC

Akquisitionen, Fusionen, Übernahmen

EQT To Start Tender Offer for Fujitec

29. Juli 2025, 23:50 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29. Juli 2025, 23:36 UTC

Market Talk

Gold Steady Ahead of FOMC Decision -- Market Talk

29. Juli 2025, 22:57 UTC

Market Talk

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29. Juli 2025, 22:50 UTC

Market Talk

Mondelez Warns of Price Increases in North America -- Market Talk

29. Juli 2025, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29. Juli 2025, 22:41 UTC

Akquisitionen, Fusionen, Übernahmen

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29. Juli 2025, 22:41 UTC

Akquisitionen, Fusionen, Übernahmen

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29. Juli 2025, 22:35 UTC

Ergebnisse

IGO Maintains Nova Life of Mine Production Guidance

29. Juli 2025, 22:35 UTC

Ergebnisse

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29. Juli 2025, 22:35 UTC

Ergebnisse

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29. Juli 2025, 22:34 UTC

Ergebnisse

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29. Juli 2025, 22:34 UTC

Ergebnisse

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29. Juli 2025, 22:34 UTC

Market Talk
Ergebnisse

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29. Juli 2025, 22:33 UTC

Ergebnisse

IGO Had A$279.7 Million of Cash at End-June

29. Juli 2025, 22:33 UTC

Ergebnisse

IGO 4Q Underlying Free Cash A$2.4 Million

29. Juli 2025, 22:33 UTC

Ergebnisse

IGO FY Sales Revenue A$512.5 Million

29. Juli 2025, 22:33 UTC

Ergebnisse

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29. Juli 2025, 22:32 UTC

Ergebnisse

IGO FY Nickel Production 17,173 Tons

29. Juli 2025, 22:32 UTC

Ergebnisse

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29. Juli 2025, 22:32 UTC

Ergebnisse

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29. Juli 2025, 22:31 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

29. Juli 2025, 22:31 UTC

Market Talk
Ergebnisse

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29. Juli 2025, 22:31 UTC

Ergebnisse

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29. Juli 2025, 22:31 UTC

Ergebnisse

IGO FY Spodumene Production 1.48 Million Tons

29. Juli 2025, 22:30 UTC

Ergebnisse

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29. Juli 2025, 22:30 UTC

Ergebnisse

IGO 4Q Underlying Ebitda A$62 Million

29. Juli 2025, 22:22 UTC

Ergebnisse

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Peer-Vergleich

Kursveränderung

Privia Health Group Inc Prognose

Kursziel

By TipRanks

50.25% Vorteil

12-Monats-Prognose

Durchschnitt 29.6 USD  50.25%

Hoch 32 USD

Tief 24 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Privia Health Group Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

6

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

23 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

157 / 375 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Privia Health Group Inc

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.